Seelos Therapeutics Inc Receivables Turnover Ratio (SEEL), from the second quarter 2024 to the second quarter 2023 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Seelos Therapeutics inc   (NASDAQ: SEEL)
 

Seelos Therapeutics Inc Accounts Receivables Turnover Ratio from the second quarter 2024 to the second quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Seelos Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2024 to a ratio of 3.87, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Seelos Therapeutics Inc in Jun 30 2024 quarter, has decreased to 94 days, compared to 103 days, in the Mar 31 2024 quarter.

If we take a look into Healthcare sector 469 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2024 from 2145 to 3045.

What is Receivable Turnover Ratio?
What is Seelos Therapeutics Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SEEL Receivables Turnover Ratio (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Receivable Change -56.38 % 22.07 % - - -
Y / Y Revenue Change -10.26 % -32.69 % 1562.5 % 1127.78 % 2105.26 %
Receivable Turnover Ratio (TTM) 3.87 3.55 4.35 4.92 4.48
SEEL's Total Ranking # 3045 # 2145 # 2368 # 2345 # 2628
Accounts Receivable average collection period days 94 103 84 74 82
Seq. Receivable Change -80.58 % 26.87 % 245.25 % -48.72 % -45.65 %
Seq. Revenue Change -36.16 % -11.43 % 50.45 % 5.49 % -52.11 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 157
Healthcare Sector # 470
Overall Market # 3045

Receivable Turnover Ratio Statistics
High Average Low
750 62.75 2.53
(Dec 31 2019)   (Dec 31 2016)





SEEL Company Profile • Back to SEEL Efficiency Comparisons • Compare SEEL Receivables Turnover Ratio to its Competitors

Financial Statements
Seelos Therapeutics Inc 's Accounts Receivable $ 0 Millions Visit SEEL's Balance sheet
Seelos Therapeutics Inc 's Sales TTM $ 2 Millions Visit SEEL's Income Statement
Sources of SEEL's Revenues Visit SEEL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SEEL's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SEEL's Growth Rates SEEL's Roa SEEL's Inventory Turnover Ratio SEEL's Dividend Comparisons
SEEL's Profitability Ratios SEEL's Roi SEEL's Asset Turnover Ratio SEEL's Dividend Growth
SEEL's Valuation Ratios SEEL's Roe SEEL's Financial Strength Ratios SEEL's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2024 Receivable at quarter ending Jun 30 2024
Sonida Senior Living Inc   30.09 $ 268.040  Millions$ 8.908  Millions
Clearside Biomedical Inc   28.61 $ 7.524  Millions$ 0.263  Millions
Aquestive Therapeutics Inc   27.56 $ 58.360  Millions$ 2.118  Millions
Fortrea Holdings Inc   27.38 $ 2,876.300  Millions$ 105.050  Millions
National Vision Holdings Inc   27.21 $ 2,033.015  Millions$ 74.709  Millions
Cv Sciences Inc   26.63 $ 14.932  Millions$ 0.561  Millions
Generation Bio Co   26.39 $ 13.174  Millions$ 0.499  Millions
Anika Therapeutics Inc   25.07 $ 165.185  Millions$ 6.590  Millions
Orchestra Biomed Holdings Inc   25.05 $ 2.079  Millions$ 0.083  Millions
Arvinas Inc   23.77 $ 93.300  Millions$ 3.925  Millions
Kymera Therapeutics Inc   23.61 $ 88.550  Millions$ 3.750  Millions
Renalytix Plc  22.89 $ 2.289  Millions$ 0.100  Millions
Innoviva Inc   22.81 $ 377.027  Millions$ 16.532  Millions
Agenus Inc  22.75 $ 159.630  Millions$ 7.015  Millions
Kiniksa Pharmaceuticals International Plc  22.32 $ 338.930  Millions$ 15.188  Millions
U S Physical Therapy Inc  22.07 $ 627.673  Millions$ 28.444  Millions
Cytomx Therapeutics Inc   21.94 $ 119.569  Millions$ 5.451  Millions
Bespoke Extracts Inc  21.65 $ 1.047  Millions$ 0.048  Millions
Fortress Biotech Inc   20.74 $ 82.624  Millions$ 3.984  Millions
Inmed Pharmaceuticals Inc  20.51 $ 5.331  Millions$ 0.260  Millions
Editas Medicine Inc   20.47 $ 67.033  Millions$ 3.275  Millions
Neuraxis Inc   20.46 $ 2.267  Millions$ 0.111  Millions
Innovage Holding Corp   19.96 $ 763.855  Millions$ 38.273  Millions
Innovative Eyewear Inc   18.25 $ 1.530  Millions$ 0.084  Millions
Hookipa Pharma inc   18.18 $ 52.163  Millions$ 2.870  Millions
Zomedica Corp   18.12 $ 25.267  Millions$ 1.394  Millions
Jrsis Health Care Corp  17.78 $ 4.516  Millions$ 0.254  Millions
Co diagnostics Inc   17.43 $ 9.137  Millions$ 0.524  Millions
Milestone Scientific Inc   17.23 $ 8.408  Millions$ 0.488  Millions
Scynexis Inc   17.22 $ 9.666  Millions$ 0.561  Millions

Date modified: 2026-10-07T00:41:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.